GRACEcast ALL Subjects audio and video cover logo

NanoString Treatment for Kidney Cancer

2m · GRACEcast ALL Subjects audio and video · 24 Jul 19:00

NanoString Technology may help doctors learn what is driving tumor growth in kidney cancer patients and, therefore, determine what treatments may be most effective for them.

The episode NanoString Treatment for Kidney Cancer from the podcast GRACEcast ALL Subjects audio and video has a duration of 2:03. It was first published 24 Jul 19:00. The cover art and the content belong to their respective owners.

More episodes from GRACEcast ALL Subjects audio and video

Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy?

Dr. Nasser Hanna outlines the possible benefits of consolidation chest radiation for small cell lung cancer patients who respond well to chemotherapy.

Management of Rare Kidney Tumors

What puts you at risk for inherited kidney cancer? Dr. Nizar Tannir discusses the signs doctors look for to determine if a kidney cancer patient should be screened for a familial syndrome.

Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation?

The doctors discuss the circumstances under which small cell lung cancer patients should receive prophylactic cranial irradiation.

NanoString Treatment for Kidney Cancer

NanoString Technology may help doctors learn what is driving tumor growth in kidney cancer patients and, therefore, determine what treatments may be most effective for them.

Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?

Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.

Every Podcast » GRACEcast ALL Subjects audio and video » NanoString Treatment for Kidney Cancer